The findings add to a growing body of evidence that treatment de-escalation is feasible and safe for favorable-risk early ...

The research group of prof. Sanjiv Luther at the department of immunobiology of the University of Lausanne has discovered that a fibroblast subtype is essential for coordinating certain immune cells ...

Adoption of recommendations to skip sentinel lymph node biopsy (SLNB) in older women with hormone-receptor (HR)-positive, HER2-negative early-stage breast cancer may be slowly gaining traction in the ...

In patients with relapsed/refractory mantle cell lymphoma (MCL) who were naive to Bruton tyrosine kinase inhibitor (BTKi) therapy, brexucabtagene autoleucel (brexu-cel) was associated with high ...

In aggressive lymphomas, inflammatory messengers reprogram the "conductors" of the immune system, causing lymph nodes structure to collapse. A team led by Simon Haas describes in "Nature Cancer" this ...

Diagnosis hinges on excisional lymph node biopsy demonstrating Reed–Sternberg cells with mixed inflammatory infiltrate, followed by CT/PET staging; labs and infrequent marrow biopsy assess systemic ...

Nodular sclerosis disease often involves mediastinal nodes and shows fibrous bands partitioning lymphoid tissue into nodules around Reed–Sternberg cells. Definitive workup requires excisional lymph ...

What is a lymph node biopsy? A lymph node biopsy is a procedure to take out all or part of a lymph node to check it for cancer cells. (If you have tumors only outside of your lymph nodes, your ...

• BTK inhibitors are a type of targeted therapy for mantle cell lymphoma that works by blocking a specific enzyme, BTK, which is crucial for the cancer cells’ survival and spread. This interference ...

• BTK inhibitors work by targeting and blocking the BTK enzyme, which is crucial for the survival and growth of cancerous B-cells in mantle cell lymphoma (MCL). This cuts off the cancer cell’s support ...

Intravascular large B-cell lymphoma (IVLBCL) is a rare subtype of diffuse large B-cell lymphoma, with nodal involvement being particularly uncommon. Due to its atypical clinical presentation, timely ...

Mantle Cell Lymphoma (MCL) is a subtype of B-cell lymphoma characterized by varied clinical manifestations. The immune status is associated with MCL’s development and outcome. This study aims to ...